Prostate Cancer Clinical Trials Consortium

This study is testing whether adding enzalutamide to talazoparib works better than talazoparib alone for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The trial includes 126 men whose cancer has specific genetic changes and …

This international study is creating a large registry to track the treatment journeys and health outcomes of over 5,000 men with advanced prostate cancer. Participants will be followed for at least five years across multiple countries to understand how care differs and what treat…